HIV Drugs: Trigger of Autoimmunity

Implicit, severe immune sensitive reactions to the anti-HIV drug abacavir materialize through an autoimmune procedure, resulting from the design of drug-induced immunizing agent that are attacked by the body's immune system as all HIV Drugs blocks protein synthesis and enzymes which cause alteration in and enzyme synthesis, autoimmune deformities accrue in HIV Patient and proteins. Many times foreign myalgia’s and arthralgia’s occur in about 5% of patients with HIV, sometimes in association with HIV seroconversion.  Many bone related diseases and HIV-associated arthralgia started progresses towards inflammatory joint disease and disorders because of HIV Treatment.

    Related Conference of HIV Drugs: Trigger of Autoimmunity

    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    July 29-30, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    November 12-13, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    November 14-15, 2019

    International Conference on Vaccines and Immune Response

    Istanbul, Turkey
    November 14-15, 2019

    Annual Congress on Antibiotics and Antimicrobial Resistance

    Geneva, Switzerland
    November 21-22, 2019

    World Conference on Vaccine and Immunology

    Dubai, UAE

    HIV Drugs: Trigger of Autoimmunity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in